GCG and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss: Currently, GLP-2 analogs like teduglutide are approved for enhancing intestinal absorption in short bowel syndrome (SBS) [42], and other GLP-2 agonists are under development or investigation [43].